TY - JOUR
KW - Adverse events
KW - Colchicine prophylaxis
KW - gout
KW - Prognostic factors
KW - urate-lowering therapy
AU - R. Bajpai
AU - R. Partington
AU - S. Muller
AU - H. Forrester
AU - C. Mallen
AU - L. Clarson
AU - N. Padmanabhan
AU - R. Whittle
AU - E. Roddy
AD - School of Medicine, Keele University, Keele, UK.
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.
Haywood Academic Rheumatology Centre, Midlands Partnership University NHS Foundation Trust, Stoke-on-Trent, UK.
AN - 38636489
BT - Rheumatology (Oxford)
DO - 10.1093/rheumatology/keae229
DP - NLM
ET - 2024/04/19
LA - eng
N1 - 1462-0332
Bajpai, Ram
Orcid: 0000-0002-1227-2703
Partington, Richard
Muller, Sara
Forrester, Harry
Mallen, Christian D
Clarson, Lorna
Padmanabhan, Nishita
Whittle, Rebecca
Roddy, Edward
Journal Article
England
Rheumatology (Oxford). 2024 Apr 18:keae229. doi: 10.1093/rheumatology/keae229.
PY - 2024
SN - 1462-0324
T2 - Rheumatology (Oxford)
TI - Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study
ER -